Everpureon Track for Record High Close -- Data Talk
Dow Jones2026/10/08 14:19Everpure, Inc. Class A (P) is currently at $153.38, up $0.72 or 0.47% --Would be new all-time closing high (Based on available data back to Oct. 7, 2015) --On pace for largest percent increase since Oct. 7, 2026, when it rose 3.71% --Currently up 11 consecutive days; up 39.88% over this period --Longest winning streak since Nov. 10, 2023, when it rose for 11 straight trading days --Best 11 day stretch since the 11 days ending Aug. 18, 2026, when it rose 46.07% --Up 17.28% month-to-date --Up 128.89% year-to-date; on pace for best year on record (Based on available data back to Oct. 7, 2015) --Up 63.83% from 52 weeks ago (Oct. 9, 2025), when it closed at $93.62 --Would be a new 52-week closing high --Up 169.13% from its 52-week closing low of $56.99 on March 30, 2026 --Traded as high as $155.00; new all-time intraday high (Based on available data back to Oct. 7, 2015) --Up 1.53% at today's intraday high All data as of 10:17:30 AM ET Source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 08, 2026 10:19 ET (14:19 GMT)
Everpure, Inc. Class A (P) is currently at $153.38, up $0.72 or 0.47%
--Would be new all-time closing high (Based on available data back to Oct. 7, 2015)
--On pace for largest percent increase since Oct. 7, 2026, when it rose 3.71%
--Currently up 11 consecutive days; up 39.88% over this period
--Longest winning streak since Nov. 10, 2023, when it rose for 11 straight trading days
--Best 11 day stretch since the 11 days ending Aug. 18, 2026, when it rose 46.07%
--Up 17.28% month-to-date
--Up 128.89% year-to-date; on pace for best year on record (Based on available data back to Oct. 7, 2015)
--Up 63.83% from 52 weeks ago (Oct. 9, 2025), when it closed at $93.62
--Would be a new 52-week closing high
--Up 169.13% from its 52-week closing low of $56.99 on March 30, 2026
--Traded as high as $155.00; new all-time intraday high (Based on available data back to Oct. 7, 2015)
--Up 1.53% at today's intraday high
All data as of 10:17:30 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 08, 2026 10:19 ET (14:19 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
